(GF, lateral ventricle injection of 10 μg/kg), and GF+MCAO groups.
Flow cytometry. Cells were treated with PE-Cy5-conjugated anti-CD11b, fluorescein isothiocyanate (FITC)-conjugated anti-MHC class I, FITC-conjugated anti-MHC class II, APC-conjugated anti-CD80 and PE-conjugated anti-CD86 antibodies or C57BL/6 mice control IgG (Biolegend, Copenhagen, Denmark) in PBS. We used standard gating strategies for fluorescence-activated cell sorting (FACS) using appropriate isotype control antibodies. Data was collected on a FACSCalibur™ (BD Biosciences) and analyzed using FACSDiva™ software version 6.1.2 (BD Biosciences).
Results
Brain ischemia/reperfusion induces serine phosphorylation of ANXA1. Here, We detected serine phosphorylation levels of ANXA1 in brain tissue of a mouse model of middle cerebral artery occlusion (MCAO) by SDS-PAGE using a phospho-serine specific antibody. Serine phosphorylation levels of ANXA1 were significantly increased in the MCAO group when compared to sham treated animals (n = 3, P ＜ 0.05). However, after injection of the PKC antagonist GF109203X (GF), serine phosphorylation levels of ANXA1 induced by MCAO were significantly reduced (n = 3, P ＜ 0.05)。 higher under these hypoxic conditions (*P < 0.01). In contrast, MHC class I levels do no significantly change under either hypoxic or non-hypoxic conditions, whereas CD86 levels remain elevated throughout both conditions.
